I Peace, Inc.| Cell and Gene Therapy Manufacturing, cGMP iPSCs | CDMO

I Peace, Inc. is a biotechnology startup based in the United States, specializing in cell and gene therapy contract manufacturing, specifically focusing on induced pluripotent stem cells (iPSCs) and their derived cell products. Founded in 2015 by Koji Tanabe, a prominent figure in iPSC research and a graduate of Professor Shinya Yamanaka's lab at Kyoto University, I Peace aims to make iPSCs accessible to a global audience. The company's unique technology allows for the parallel production of multiple donor-derived iPSCs without contamination concerns, enabling the provision of high-quality cells at a reasonable cost and in large quantities. I Peace not only supports drug discovery and cell therapy development for pharmaceutical and cell therapy companies but also promotes the production of iPSCs for individual use, envisioning a future where each person possesses their own iPSCs. In addition to their core services, I Peace aims to establish iPSC cell banking services for individuals, with the ultimate goal of making regenerative cell therapy widely accessible. While specific investment details are not currently available, this unique offering in the biotechnology and healthcare sector, combined with its potential to revolutionize cell therapy and personalized medicine, positions I Peace as a promising candidate for future investment opportunities in the rapidly growing field of cell and gene therapy. I Peace, Inc. has the potential to significantly impact the future landscape of regenerative medicine and personalized healthcare.